Authors: KELDSEN N MADSEN EL HAVSTEEN H KAMBY C LAURSEN L SANDBERG E

Citation: N. Keldsen et al., ORAL TREOSULFAN AS 2ND-LINE TREATMENT IN PLATINUM-RESISTANT OVARIAN-CANCER - A PHASE-II STUDY, Gynecologic oncology, 69(2), 1998, pp. 100-102

Authors: KELDSEN N MICHALSKI W BENTZEN SM HANSEN KB THORLING K

Citation: N. Keldsen et al., RISK-FACTORS FOR CENTRAL-NERVOUS-SYSTEM INVOLVEMENT IN NON-HODGKINS-LYMPHOMA - A MULTIVARIATE-ANALYSIS, Acta oncologica, 35(6), 1996, pp. 703-708

Authors: KELDSEN N MICHALSKI W BENTZEN SM THORLING K

Citation: N. Keldsen et al., CNS INVOLVEMENT IN NON-HODGKINS-LYMPHOMA (NHL), European journal of cancer, 31A, 1995, pp. 791-791

Authors: KELDSEN N BJERRUM OW DAHL IMS DRIVSHOLM A ELLEGAARD J GADEBERG O GIMSING P GRONVOLD T HANSEN MM HIPPE E LAMVIK J LY B SKARBOVIK A TALSTAD I THORLING K WESENBERG K WISLOFF F

Citation: N. Keldsen et al., MULTIPLE-MYELOMA TREATED WITH MITOXANTRONE IN COMBINATION WITH VINCRISTINE AND PREDNISOLONE (NOP REGIMEN) VERSUS MELPHALAN AND PREDNISOLONE- A PHASE-III STUDY, European journal of haematology, 51(2), 1993, pp. 80-85